[TLX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -101.99%
YoY- -307.87%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/00 CAGR
Revenue 1,607 1,818 0 0 0 0 0 -
PBT -25,096 -17,125 -5,190 -3,143 1,550 -66 -249 25.92%
Tax -6,795 -6,756 -5,190 -76 24 -8 -249 17.96%
NP -18,301 -10,370 -5,190 -3,143 1,512 -66 0 -
Tax Rate - - - - -1.54% - - -
Total Cost 19,908 12,187 5,190 3,143 -1,512 66 0 -
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/00 CAGR
NP Margin -1,138.83 -570.54 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/00 CAGR
EPS -0.07 -0.05 -0.03 -1.28 0.01 0.00 0.00 -
EPS Diluted -0.07 -0.05 -0.03 -1.28 0.01 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.